
About Hemarus Therapeutics Limited
Data last updated:
Hemarus Therapeutics Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 September 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74220TG2003PLC041698. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹10 Lakh. It was formerly known as Hemarus Therapeutics Private Limited and Credence Clinical Research Private Limited. It is led by directors including Kavali Dharmendra and Balaraju Jittaboina.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
The company has about 67 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Hemarus. As per MCA filings, the company has satisfied charges of ₹75.4 Cr on record. Court records list 14 cases involving the company, including 9 filed by the company and 5 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hemarus.co.in.
Company details
Name history
Hemarus Therapeutics has undergone 2 name changes throughout its history. The company was previously known as Hemarus Therapeutics Private Limited, and Credence Clinical Research Private Limited. The current legal name is Hemarus Therapeutics Limited.
| Company Name | Status |
|---|---|
| Hemarus Therapeutics Limited | Current |
| Hemarus Therapeutics Private Limited | Previous |
| Credence Clinical Research Private Limited | Previous |
CIN history
Hemarus Therapeutics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74220TG2003PLC041698, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74220TG2003PLC041698 | Current |
| U74220AP2003PTC041698 | Previous |
| U74220AP2003PLC041698 | Previous |
Contact details
Hemarus Therapeutics Limited's registered office is in Hyderabad, Telangana. Its website is hemarus.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address8 – 2 – 293/82/Jiii/359, Plot No.359 – III Raod No.80 Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryLife Sciences, Biotechnology
To see the full contact details of Hemarus Therapeutics Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Hemarus Therapeutics operates one associated brand: Hemarus. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specialty plasma derived biopharmaceuticals for bleeding disorders | hemarus.co.in |
Business activity
The main business activity of Hemarus Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Hemarus Therapeutics Limited
FY 2025 filings availableHemarus Therapeutics Limited reported revenue of ₹900 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 93% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hemarus Therapeutics Limited, buy the company report.
Board of directors of Hemarus Therapeutics Limited
Hemarus Therapeutics has 3 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kavali Dharmendra Also directs: Annapurnavijaya Bio Nutrients LLP, Lifestyle Industries LLP, Tavuk Farms LLP and 1 more | Director | 25 Oct 2024 | 2 Years 0 Months | Current |
| Balaraju Jittaboina | Director | 25 Oct 2024 | 2 Years 0 Months | Current |
| Santosh Kumar Surana Also directs: KSR Samriddhi Ventures LLP | Director | 25 Oct 2024 | 2 Years 0 Months | Current |
Auditor
Hemarus Therapeutics Limited is audited by Ganeshvenkat & Co for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ganeshvenkat & Co | FY 2022 | 005293S |
Shareholding
The shareholding of Hemarus Therapeutics Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hemarus Therapeutics Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Feb 2011 | 10280683 | Indian Overseas Bank | ₹66.68 Cr | Satisfied | |
| 10 Aug 2004 | 90131380 | Andhra Pradesh State Financial Corporation | ₹8.72 Cr | Satisfied |
To see the full charge records of Hemarus Therapeutics Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Hemarus Therapeutics Limited has 14 court cases on record: 9 filed by Hemarus Therapeutics, 5 filed against it. 3 cases are pending and 11 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 0 | 2 |
| District courts | 4 | 4 | 1 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (CHAMBER SUMMONS) | Filed against the company by Naxpar Medicamentos LLP Through Kishor Tambe | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by Naxpar Medicamentos LLP Through Kishor Tambe | Disposed |
| District court, Medchal Malkajgiri, Telangana | Court case (AS) | Filed against the company | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against State of Telangana, Department of Health and Medical and 1 other | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against State of Telangana, and 1 other | Pending |
To see the full case history of Hemarus Therapeutics Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hemarus Therapeutics Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Hemarus Therapeutics Limited has a workforce of 67 employees on its EPFO records as of May 2021, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2021-22 | 67 |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 | |
| FY 2014-15 |
To see the full employee and EPFO history of Hemarus Therapeutics Limited, buy the company report.
GST
Hemarus Therapeutics has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Hemarus Therapeutics Limited, buy the company report.
Recent activity
Hemarus Therapeutics Limited has 18 board changes on record since 2013: 3 appointments and 15 cessations. The latest: Ramana Reddy Malireddy ceased to be Irp/Rp/Liquidator on 21 Dec 2024.
15 earlier events are in the company report.
Frequently asked questions
Hemarus Therapeutics is an active public limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 September 2003 (23+ years old) and is registered under CIN U74220TG2003PLC041698.
Hemarus Therapeutics has 3 current directors:
- Kavali Dharmendra - Director
- Balaraju Jittaboina - Director
- Santosh Kumar Surana - Director
The latest financial statements of Hemarus Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Hemarus Therapeutics has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Hemarus Therapeutics is U74220TG2003PLC041698. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hemarus Therapeutics has 14 court cases on record: 9 filed by the company and 5 filed against it. 3 are pending. Most are in the high courts.
Hemarus Therapeutics was incorporated on 16 September 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.
Ramana Reddy Malireddy ceased to be Irp/Rp/Liquidator on 21 Dec 2024. Balaraju Jittaboina was appointed as Director on 25 Oct 2024. Kavali Dharmendra was appointed as Director on 25 Oct 2024. Hemarus Therapeutics has 18 board changes on record in total.
Hemarus Therapeutics can be reached through the website hemarus.co.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Hemarus Therapeutics is at 8 – 2 – 29382Jiii359, Plot No.359 – III Raod No.80 Jubilee Hills, Hyderabad, Telangana, India – 500033.

